Llwytho...
Study design of PANGAEA 2.0, a non-interventional study on RRMS patients to be switched to fingolimod
BACKGROUND: The therapeutic options for patients with Multiple Sclerosis (MS) have steadily increased due to the approval of new substances that now supplement traditional first-line agents, demanding a paradigm shift in the assessment of disease activity and treatment response in clinical routine....
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | BMC Neurol |
|---|---|
| Prif Awduron: | , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
BioMed Central
2016
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4977700/ https://ncbi.nlm.nih.gov/pubmed/27502119 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12883-016-0648-6 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|